Wis Medical Inc.

Based in South Korea, Wis Medical Inc. specializes in advanced soft wearable technology that enhances healthcare diagnostics and remote monitoring through innovative products like the Tedream™ sleep monitoring patch. Wis Medical Inc. was founded in 2022 in Yongin-si, South Korea, focusing on developing healthcare solutions through wearable technologies.

The company, co-founded by Josh Lee and W. Hong Yeo, has successfully completed 2 deals to date. The latest funding round occurred on April 1, 2026, raising KRW 2 billion from investor Provest Partners, contributing to a total amount raised of KRW 2 billion. Wis Medical Inc.

specializes in innovative soft wearable technology aimed at revolutionizing healthcare diagnostics and remote monitoring. The company's flagship product, the Technology Enhanced Dreaming patch (Tedream™), leverages advanced sensor systems to monitor cardiopulmonary sounds and vital biometrics with high accuracy. Tedream™ provides an at-home sleep monitoring solution that integrates multiple sensors in a compact, wireless format, delivering insights comparable to traditional polysomnography (PSG). The devices are designed for a wide user base, accommodating individuals from infants to the elderly, and are utilized both in-home for personal health management and in hospitals for automated diagnostics.

Wis Medical's products are marketed not only in South Korea but also in the United States, catering to healthcare providers and patients seeking efficient and effective medical services. Wis Medical's revenue structure is facilitated through direct-to-consumer sales as well as B2B partnerships with healthcare providers. The company’s offerings, particularly the Tedream™ sleep monitoring device, provide a subscription-based model for continuous data monitoring and analysis, enhancing the user experience and ensuring ongoing engagement with clients. Wis Medical also emphasizes secured cloud technology to store and manage health data, which adds value for healthcare institutions looking to improve patient outcomes through data-driven insights.

The pricing structure for their products is designed to appeal to both individual consumers and institutional partners, ensuring accessibility while maintaining service efficiency. In April 2026, Wis Medical Inc. raised KRW 2 billion in venture funding from new investor Provest Partners. The company plans to utilize this funding to design and launch upcoming new products that enhance their wearable technology.

Additionally, Wis Medical aims to expand into international markets, particularly in North America and Europe, by the end of 2026, seeking to establish a broader presence in the healthcare technology sector.